Rajesh Tope, Health Minister, Maharashtra inaugurates BSV R&D centre
Bharat Serums and Vaccines (BSV) to spur innovation and scientific research has opened a world-class R&D centre at Airoli, Maharashtra. The state-of-art centre was inaugurated by Rajesh Tope, Health Minister, Maharashtra. Also present at the event were Sanjiv Navangul, MD & CEO, BSV, Vishwanath Swarup, COO, India Business and Dr Jaby Jacob, Head, R&D. The R&D centre will endeavour to bring scientifically advanced biological, biotechnology products and novel drug delivery systems that deliver better patient outcomes in Women’s Health, Assisted Reproductive Technology and Critical Care & Emergency Medicines.
Sanjiv Navangul, MD & CEO, BSV shared, “At BSV, we are driven by our vision of bringing life to life through our pioneering innovations that deliver healthy patient outcomes. Our 100+ scientists at the R&D centre continue to demonstrate our commitment towards Aatmanirbhar Bharath, as we innovate in Maharashtra for India and the world. BSV’s Anti-Rho (D) immunoglobulin product is the world’s first marketed recombinant Anti-D with patents in India, the US, Europe, Australia and Canada. We are the only Indian company to have developed the immunosuppressive Anti-thymocyte globulin and deliver treatments for Neglected Tropical Diseases (snakebites, rabies) that predominantly affect vulnerable populations of India living in rural and remote locations.
